Company: SXTPW
Filing Date: 2025-08-27
Form Type: DEF 14A
Source: 0001213900-25-080878
Chunk: 25

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-27
Form: DEF 14A
Chunk 25
---
 has access to management
and outside advisers as follows:

| ● | Access to Management and Employees. Directors have full and unrestricted access to the management and employees of the Company. Additionally, key members of management attend Board meetings to present information about the results, plans and operations of the business within their areas of responsibility. |

| ● | Access to Outside Advisors. The Board and its committees may retain counsel or consultants without obtaining the approval of any officer of the Company in advance or otherwise. The Audit Committee has the sole authority to retain and terminate the independent auditor. The Nominating and Corporate Governance Committee has the sole authority to retain search firms to be used to identify director candidates. |

.
The Board maintains overall responsibility for overseeing the Company’s risk management, including succession planning, product
safety and information and digital security. In furtherance of its responsibility, the Board has delegated specific risk-related responsibilities
to the Audit Committee.

The Audit Committee engages in substantive discussions
of risk management at its regular committee meetings held during the year. At these meetings, it receives functional risk review reports
covering significant areas of risk from the employees responsible for these functional areas, as well as receiving reports from the Chief
Financial Officer who reports directly to the Chairperson of the Audit Committee. The Audit Committee also receives reports at each meeting
regarding legal and regulatory risks from management and meets in separate executive sessions with our independent auditors and our Chief
Financial Officer. The Audit Committee provides a summary to the full Board at certain Board meetings of the risk area reviewed together
with any other risk related subjects discussed at the Audit Committee meeting.

.
Information security and privacy has been and remains of the utmost importance to the Company in light of the value we place on maintaining
the trust and confidence of our customers, employees and other stakeholders. Accordingly, our Chief Executive Officer and President advises
the Audit Committee and the full Board at least once per year on our program for managing information security risks, including data privacy
and data protection risks.

. Stockholders
and other parties interested in communicating directly with individual directors, the non-management directors as a group or the entire
Board may do so by writing to the Nominating and Corporate Governance Committee, c/o Nominating and Corporate Governance Committee Chairman,
60 Degrees Pharmaceuticals, Inc., 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036.

The Nominating and Corporate Governance Committee
has approved a process for handling letters received by the Company and addressed to individual directors, non-management members